Transgender Women and Pre-Exposure Prophylaxis for HIV Prevention
December 2015 | National Center for Innovation in HIV Care Samantha Marquez and Sean Cahill
““... transgender women are an underserved population, not only in terms of HIV treatment, but also in terms of HIV prevention and medical care of their HIV disease.””
The National Center for Innovation in HIV Care has published an issue brief on transgender women and PrEP. The brief examines the inclusion of transgender women in PrEP research and reviews the recent Lancet article about data from the iPrEx and OLE studies. It also addresses concerns related to feminizing hormones and PrEP efficacy.